ALKERMES | Lånekapital

Loan Capital Endring Dato
AbbVie USD 63.81B 8.17B 2024-03
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 287.09M 635K 2024-03
Amgen USD 60.06B 3.11B 2024-03
Biogen USD 6.29B 498.1M 2024-03
BioMarin Pharmaceutical USD 593.6M 510K 2024-03
Bristol-Myers Squibb USD 49.49B 17.35B 2024-03
Eli Lilly USD 24.56B 6.64B 2024-03
Gilead Sciences USD 21.53B 1.66B 2024-03
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.23B 1.43M 2024-03
J&J USD 25.08B 969M 2024-03
Malin Corporation EUR 0 0 2021-12
Merck USD 31.14B 2.83B 2024-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Otsuka Holdings JPY 68.67B 57.24B 2024-03
Pfizer USD 60.48B 571M 2024-03
Regeneron Pharmaceuticals USD 1.98B 719.6M 2024-03



ALKERMES Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.